Age-Dependent Changes in FasL (CD95L) Modulate Macrophage Function in a Model of Age-Related Macular Degeneration
Open Access
- 1 August 2013
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 54 (8) , 5321-5331
Abstract
Purpose. We examined the effect of aging on Fas ligand (FasL) function in a mouse model of choroidal neovascularization (CNV). Methods. Young and aged mice were laser treated to induce CNV. Bone marrow chimeras were performed between young and aged mice. FasL protein expression was examined in the eye and soluble FasL (sFasL) was measured in the blood. Young and aged mice were treated with a matrix metalloprotease (MMP) inhibitor and systemic sFasL was neutralized by antibody treatment. Macrophages from young and aged mice were tested for sFasL-mediated cytokine production and migration. Results. The elevated CNV response observed with aging was dependent on bone marrow–derived cells. FasL expression in the eye was increased with age, but decreased following laser treatment. Aged mice had higher levels of sFasL in the blood compared to young mice. Systemic treatment with an MMP inhibitor decreased bloodborne sFasL, and reduced CNV in young and aged mice. Systemic neutralization of sFasL reduced CNV only in aged mice. sFasL increased cytokine production in aged macrophages and proangiogenic M2 macrophages. Aged M2 macrophages had elevated Fas (CD95) expression and displayed increased migration in response to sFasL compared to M1 macrophages derived from young animals. Conclusions. Age modulates FasL function where increased MMP cleavage leads to a loss of function in the eye. The released form of FasL (sFasL) preferentially induces the migration of proangiogenic M2 macrophages into the laser lesions and increases proangiogenic cytokines promoting CNV. FasL may be a viable target for therapeutic intervention in aged-related neovascular disease.Keywords
This publication has 74 references indexed in Scilit:
- Mechanisms of Age-Related Macular DegenerationNeuron, 2012
- The immune system in the aging humanImmunologic Research, 2012
- Suppression and Regression of Choroidal Neovascularization in Mice by a Novel CCR2 Antagonist, INCB3344PLOS ONE, 2011
- Macrophage polarization in the maculae of age‐related macular degeneration: A pilot studyPathology International, 2011
- Disturbed Matrix Metalloproteinase Activity of Bruch's Membrane in Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2011
- Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell DeathPLOS ONE, 2011
- Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular DegenerationCurrent Drug Targets, 2011
- Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularizationCellular and Molecular Life Sciences, 2010
- Doxycycline induces membrane expression of VE‐cadherin on endothelial cells and prevents vascular hyperpermeabilityThe FASEB Journal, 2008
- Age-Related Macular DegenerationNew England Journal of Medicine, 2008